Skip to main content

Advertisement

SpringerLink
Log in

Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma

  • Invited Review
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction

Paraneoplastic syndromes (PNS) in renal cell carcinoma (RCC) are important to be recognized by the treating physician, because they may lead to diagnosis of underlying malignant disease. On the other hand, PNS may dominate the clinical picture and can hide the true disorder like a chameleon. When realized, a PNS can be used as a ‘neoplastic tumour marker’, especially in case of recurrence. Their occurrence can even be linked to prognosis of disease.

Methods

A PubMed search combining the MeSH terms renal cell carcinoma and paraneoplastic syndrome was executed in April 2015. All hits concerning these MeSH terms have been taken into account when writing this review.

Results

There is a big gap between reporting and incidence of paraneoplastic syndromes in renal cell carcinoma. Most of the articles in Medline are case reports and reviews of research done in the 1950s–1990s. One problem is that a clear definition of a paraneoplastic syndrome is still lacking. The most important PNS in RCC are hypercalcemia. It is important that PNS are not only arising in advanced stages of renal cell carcinoma; in contrast, a PNS can often be the first symptom of RCC.

Conclusion

Paraneoplastic syndromes are often unrecognized but are important biomarkers in RCC. Further research into the underlying pathomechanisms of PNS may improve our understanding of the RCC tumour biology and is urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Forman D, Bray F, Brewster DH (2017) Cancer incidence in five continents Vol. X http://www.iarc.fr/en/publications/pdfs-online/epi/sp164/CI5volX_Full.pdf. Accessed 11 May 2017

  2. Novara G, Ficarra V, Antonelli A, Artibani W, Bertini R, Carini M et al (2010) Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 58:588–595

    Article  PubMed  Google Scholar 

  3. Lee CT, Katz J, Fearn PA, Russo P (2002) Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol Semin Orig Investig 7:135–140 (Elsevier)

    Article  Google Scholar 

  4. Ding G-X, Song N-H, Feng C-C, Xia G-W, Jiang H-W, Hua L-X et al (2012) Is there an association between advanced stage of renal cell carcinoma and paraneoplastic syndrome? Med Princ Pract 21:370–374

    Article  PubMed  Google Scholar 

  5. Palapattu GS, Kristo B, Rajfer J (2002) Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. Rev Urol 4:163–170

    PubMed  PubMed Central  Google Scholar 

  6. Kim HL, Belldegrun AS, Freitas DG, Bui MHT, Han K-R, Dorey FJ et al (2003) Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol 170:1742–1746

    Article  PubMed  Google Scholar 

  7. Sacco E, Pinto F, Sasso F, Racioppi M, Gulino G, Volpe A et al (2009) Paraneoplastic syndromes in patients with urological malignancies. Urol Int 83:1–11

    Article  PubMed  Google Scholar 

  8. Mohammed Ilyas M, Turner G, Cranston D (2008) Human chorionic gonadotropin-secreting clear cell renal cell carcinoma with paraneoplastic gynaecomastia. Scand J Urol Nephrol 42:555–557

    Article  PubMed  Google Scholar 

  9. Gold PJ, Fefer A, Thompson JA (1996) Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol 14:216–222

    PubMed  CAS  Google Scholar 

  10. Ding G, Feng C, Song N, Fang Z, Xia G, Jiang H et al (2013) Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma. Urol Oncol Semin Orig Investig 31:1820–1825

    Article  CAS  Google Scholar 

  11. Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DG (1978) Non-metastatic hepatic dysfunction associated with renal carcinoma. J Urol 119:468–471

    Article  PubMed  CAS  Google Scholar 

  12. Goldberg MF, Tashjian AH, Order SE, Dammin GJ (1964) Renal adenocarcinoma containing a parathyroid hormone-like substance and associated with marked hypercalcemia. Am J Med 36:805–814

    Article  PubMed  CAS  Google Scholar 

  13. Buckle RM, McMillan M, Mallinson C (1970) Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia. Br Med J 4:724–726

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Weissglas M, Schamhart D, Löwik C, Papapoulos S, Vos P, Kurth KH (1995) Hypercalcemia and cosecretion of interleukin-6 and parathyroid hormone related peptide by a human renal cell carcinoma implanted into nude mice. J Urol 153:854–857

    Article  PubMed  CAS  Google Scholar 

  15. Muggia FM (1990) Overview of cancer-related hypercalcemia: epidemiology and etiology. Semin Oncol 17:3–9

    PubMed  CAS  Google Scholar 

  16. Mundy GR (1990) Pathophysiology of cancer-associated hypercalcemia. Semin Oncol 17:10–15

    PubMed  CAS  Google Scholar 

  17. Chasan SA, Pothel LR, Huben RP (1989) Management and prognostic significance of hypercalcemia in renal cell carcinoma. Urology 33:167–170

    Article  PubMed  CAS  Google Scholar 

  18. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530–2540

    Article  PubMed  CAS  Google Scholar 

  19. Adhikaree J, Newby Y, Sundar S (2014) Denosumab should be the treatment of choice for bisphosphonate refractory hypercalcaemia of malignancy. BMJ Case Rep 2014:bcr2013202861

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sufrin G, Mirand EA, Moore RH, Chu TM, Murphy GP (1977) Hormones in renal cancer. J Urol 117:433–438

    Article  PubMed  CAS  Google Scholar 

  21. Moein MR, Dehgahni VO (2000) Hypertension: a rare presentation of renal cell carcinoma. J Urol 164:2019

    Article  PubMed  CAS  Google Scholar 

  22. Dahl T, Eide I, Fryjordet A (1981) Hypernephroma and hypertension. Two case reports. Acta Med Scand 209:121–124

    Article  PubMed  CAS  Google Scholar 

  23. Wiesener MS, Seyfarth M, Warnecke C, Jürgensen JS, Rosenberger C, Morgan NV et al (2002) Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood 99:3562–3565

    Article  PubMed  CAS  Google Scholar 

  24. Sherwood JB, Burns ER, Shouval D (1987) Stimulation by cAMP of erythropoietin secretion by an established human renal carcinoma cell line. Blood 69:1053–1057

    PubMed  CAS  Google Scholar 

  25. Cho EJ, Lee HJ, Park KU, Kim U-Y, Lee HJ, Bang SM (2014) Immune thrombocytopenic purpura in a patient with renal cell carcinoma. Korean J Intern Med 29:671

    Article  PubMed  PubMed Central  Google Scholar 

  26. Wang Y-C, Yang S, Tzen C-Y, Lin C-C, Lin J (2006) Renal cell carcinoma producing granulocyte colony-stimulating factor. J Formos Med Assoc Taiwan Yi Zhi 105:414–417

    Article  PubMed  Google Scholar 

  27. Todenhöfer T, Wirths S, von Weyhern CH, Heckl S, Horger M, Hennenlotter J et al (2012) Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma. BMC Urol 12:7

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kirkali Z, Esen AA, Kirkali G, Güner G (1995) Ferritin: a tumor marker expressed by renal cell carcinoma. Eur Urol 28:131–134

    Article  PubMed  CAS  Google Scholar 

  29. Loughlin KR, Gittes RF, Partridge D, Stelos P (1987) The relationship of lactoferrin to the anemia of renal cell carcinoma. Cancer 59:566–571

    Article  PubMed  CAS  Google Scholar 

  30. Pavelić K, Popović M (1981) Insulin and glucagon secretion by renal adenocarcinoma. Cancer 48:98–100

    Article  PubMed  Google Scholar 

  31. Watanobe H, Yoshioka M, Takebe K (1988) Ectopic ACTH syndrome due to Grawitz tumor. Horm Metab Res Horm Stoffwechselforschung Horm Métabolisme 20:453–456

    Article  CAS  Google Scholar 

  32. Riggs BL, Sprague RG (1961) Association of cushing’s syndrome and neoplastic disease: observations in 232 cases of cushing’s syndrome and review of the literature. Arch Intern Med 108:841–849

    Article  PubMed  Google Scholar 

  33. Turkington RW (1971) Ectopic Production of Prolactin. N Engl J Med 285:1455–1458

    Article  PubMed  CAS  Google Scholar 

  34. Resnick ME, Unterberger H, McLoughlin PT (1966) Renal carcinoid producing the carcinoid syndrome. Med Times 94:895–896

    PubMed  CAS  Google Scholar 

  35. McCaffrey JA, Reuter V, Herr HW, Macapinlac HA, Russo P, Motzer RJ (2000) Carcinoid tumor of the kidney: the use of somatostatin receptor scintigraphy in diagnosis and management. Urol Oncol Semin Orig Investig 5:108–111 (Elsevier)

    Article  CAS  Google Scholar 

  36. Kwatra A, McDonald RE, Corriere JRJN (1998) Erythema gyratum repens in association with renal cell carcinoma. J Urol 159:2077

    Article  PubMed  CAS  Google Scholar 

  37. Levy O, Tishler M (2009) Acquired ichthyosis as the primary manifestation of renal cell carcinoma. Isr Med Assoc J 11:121

    PubMed  Google Scholar 

  38. Yan K, Liu C, Xu Z, Liu Z, Wang K, Jiang Y et al (2013) Renal cell carcinoma presenting as exfoliative dermatitis (erythroderma)—a case report. Clin Nephrol 80:63–66

    Article  PubMed  Google Scholar 

  39. Ducarme G, Rey D, Bryckaert P-E, Reguiai Z, Bernard P, Staerman F (2003) Paraneoplastic urticarial vasculitis and renal carcinoma]. Prog En Urol J Assoc Fr Urol Société Fr Urol 13:495–497

    Google Scholar 

  40. Rajpara A, Liolios A, Fraga G, Blackmon J (2014) Recurrent paraneoplastic wells syndrome in a patient with metastatic renal cell cancer. Dermatol Online J 20(6)

  41. Yilmaz S, Karakas A, Cinar M, Coskun O, Simsek I, Erdem H et al (2013) Adult onset still’s disease as a paraneoplastic syndrome. Bull Hosp Joint Dis 71:156–160

    Google Scholar 

  42. Moscardi JL, Macedo NA, Espasandin JA, Piñeyro MI (1993) Malignant acanthosis nigricans associated with a renal tumor. Int J Dermatol 32:893–894

    Article  PubMed  CAS  Google Scholar 

  43. Saravanan K, Baer ST, Meredith A, Dyson A, von der Werth J (2006) Benign mucous membrane pemphigoid of the upper aero-digestive tract: rare paraneoplastic syndrome presentation in renal cell carcinoma. J Laryngol Otol 120:237–239

    Article  PubMed  CAS  Google Scholar 

  44. Vanatta PR, Silva FG, Taylor WE, Costa JC (1983) Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature. Hum Pathol 14:195–201

    Article  PubMed  CAS  Google Scholar 

  45. Schaefer O, Lohrmann C, Harder J, Veelken H, Langer M (2004) Treatment of renal cell carcinoma-associated dermatomyositis with renal arterial embolization and percutaneous radiofrequency heat ablation. J Vasc Interv Radiol JVIR 15:97–99

    Article  PubMed  Google Scholar 

  46. Harrison JW, Cherukuri R, Buchan D (2015) Renal cell carcinoma presenting with paraneoplastic hallucinations and cognitive decline from limbic encephalitis. J Gen Intern Med 30:1037–1040

    Article  PubMed  PubMed Central  Google Scholar 

  47. Johnson V, Friedman N, Haller NA, Hagel C (2008) Immune mediated neurologic dysfunction as a paraneoplastic syndrome in renal cell carcinoma. J Neurooncol 90:279–281

    Article  PubMed  Google Scholar 

  48. Thomas NE, Passamonte PM, Sunderrajan EV, Andelin JB, Ansbacher LE (1984) Bilateral diaphragmatic paralysis as a possible paraneoplastic syndrome from renal cell carcinoma. Am Rev Respir Dis 129:507–509

    PubMed  CAS  Google Scholar 

  49. McHugh JC, Murray B, Renganathan R, Connolly S, Lynch T (2007) GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord 22:1343–1346

    Article  PubMed  Google Scholar 

  50. Turk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B et al (2009) Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract 18:73–75

    Article  PubMed  Google Scholar 

  51. Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349:1543–1554

    Article  PubMed  CAS  Google Scholar 

  52. Stauffer JM, Granville GE, Law SW (1961) Recurrent hypoglycemia and retroperitoneal fibrosarcoma. N Engl J Med 265:979–982

    Article  PubMed  CAS  Google Scholar 

  53. Aoyagi T, Mori I, Ueyama Y, Tamaoki N (1989) Sinusoidal dilatation of the liver as a paraneoplastic manifestation of renal cell carcinoma. Hum Pathol 20:1193–1197

    Article  PubMed  CAS  Google Scholar 

  54. Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, Négrier S et al (1997) Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer J Int Cancer 72:424–430

    Article  CAS  Google Scholar 

  55. Giannakos G, Papanicolaou X, Trafalis D, Michaelidis I, Margaritis G, Christofilakis C (2005) Stauffer’s syndrome variant associated with renal cell carcinoma. Int J Urol 12:757–759

    Article  PubMed  Google Scholar 

  56. Kurban M, Uthman I, Kibbi A-G, Ghosn S (2008) Acquired perforating dermatosis heralding metastatic renal cell carcinoma to the liver. Int J Dermatol 47:1038–1040

    Article  PubMed  Google Scholar 

  57. Ibrahim TM, Iheonunekwu N (2009) Secondary amyloidosis of the conjunctiva and mucosa of upper respiratory tract associated with renal cell carcinoma: case report and review of literature. Niger J Med J Natl Assoc Resid Dr Niger 18:172–174

    CAS  Google Scholar 

  58. Triginer C, Fernández R, Sánchez JM, Net A (1989) Dermatomyositis and hypernephroma. Rev Clínica Esp 184:110

    CAS  Google Scholar 

  59. Nevins E, Zayat AS, Browning AJ, Biyani CS, Jarrett S (2013) Renal cell carcinoma-associated adult dermatomyositis treated laparoscopic nephrectomy. Urol Ann 5:299–301

    Article  PubMed  PubMed Central  Google Scholar 

  60. Sarma PK, Aggarwal A, Misra R, Chauhan A, Agarwal V (2011) Renal cell carcinoma and systemic onset juvenile idiopathic arthritis. Indian J Med Sci 65:107–111

    Article  PubMed  Google Scholar 

  61. Lee CM, Sim A, Kurugulasigamoney G, Ng LG (2015) Heart failure as the first manifestation of renal cell carcinoma. Korean J Urol 56:82

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Eberhard Karls University Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany

    M. Hegemann, A. Stenzl & J. Bedke

  2. Department of Urology, Ernst-Moritz-Arndt University Greifswald, Ferdinand Sauerbruch Str, 17475, Greifswald, Germany

    N. Kroeger

Authors
  1. M. Hegemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Kroeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Stenzl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Bedke
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MH, NK, JB designed the review. MH and NK collected data. MH, NK, AS, JS drafted the manuscript. AS and JB provided intellectual contribution to the work. AS and JB did the supervision of the project.

Corresponding author

Correspondence to J. Bedke.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hegemann, M., Kroeger, N., Stenzl, A. et al. Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma. World J Urol 36, 849–854 (2018). https://doi.org/10.1007/s00345-018-2215-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-018-2215-9

Keywords

Search

Navigation